4Front Ventures Corp. Debt Instrument, Increase, Accrued Interest

Prices Financial Statements ›Discontinued ›Insider Transactions Breakdown

Balance Sheet ›Income Statement ›Expense Statement ›Shareholders' Equity ›Cash Flow ›Notes ›

Equity Securities, FV-NI, Cost Security Deposit Intangible Assets ›Commitment and Contingencies ›Debt ›Equity ›Compensation Related Costs ›Income Taxes ›Number of Operating Segments Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation ›Fair Value Measures and Disclosures ›Leases ›Accounting Profit Acquisitions Through Business Combinations Biological Assets Additional Liabilities Contingent Liabilities Recognised In Business Combination Additional Recognition Goodwill Additions From Purchases Biological Assets Additions To Rightofuse Assets Inventory ›Adjustments For Decrease Increase In Loans And Advances To Customers Receivables ›Adjustments For Increase Decrease In Other Operating Payables Adjustments For Increase Decrease In Trade Account Payable Applicable Tax Rate Assets Biological Assets Cash Cash Advances And Loans From Related Parties Cash And Cash Equivalents Cash Repayments Of Advances And Loans From Related Parties Contingent Consideration Recognised As Of Acquisition Date Contractual Commitments For Acquisition Of Property Plant And Equipment Derivative Instruments and Hedging Activities ›Current Accrued Expenses And Other Current Liabilities Current Assets Current Biological Assets Current Borrowings And Current Portion Of Noncurrent Borrowings Current Liabilities Current Prepaid Expenses Current Tax Liabilities Current Tax Liabilities Current Decrease Due To Harvest Biological Assets Deferred Income Classified As Current Deferred Income Classified As Noncurrent Description Of Expected Volatility Share Options Granted Description Of Option Life Share Options Granted Description Of Risk Free Interest Rate Share Options Granted Entity Public Float Equity Equity And Liabilities Increase Decrease Through Exercise Of Warrants Equity Increase Decrease Through Other Contributions By Owners Investment Accounted For Using Equity Method Issued Capital Liabilities Longterm Deposits Maximum Exposure To Credit Risk Noncontrolling Interests Noncurrent Payables To Trade Suppliers Noncurrent Portion Of Noncurrent Notes And Debentures Issued Noncurrent Restricted Cash And Cash Equivalents Nonderivative Financial Liabilities Undiscounted Cash Flows Shares ›Other Reserves Percentage Of Reasonably Possible Decrease In Unobservable Input Liabilities Profit Loss Attributable To Noncontrolling Interests Profit Loss Attributable To Owners Of Parent Profit Loss Before Tax Profit Loss Of Acquiree Profit Loss Of Combined Entity Purchase Of Investments Other Than Investments Accounted For Using Equity Method Raw Materials And Consumables Used Rent Deferred Income Classified As Current Retained Earnings Rightofuse Assets Tax Effect Of Foreign Tax Rates Trade And Other Current Payables Trade And Other Current Payables To Trade Suppliers Trade And Other Payables Undiscounted Cash Flows Wages And Salaries

Debt Instruments ›Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net Debt Instruments Held

Long-term Debt, Gross Debt Instrument, Interest Rate, Stated Percentage Debt Instrument, Increase, Accrued Interest

4Front Ventures Corp. Debt Instrument, Increase, Accrued Interest

4Front Ventures Corp. reported Debt Instrument, Increase, Accrued Interest of $7.36 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-14.

Discontinued › Notes › Debt › Debt Instruments

us-gaap:DebtInstrumentIncreaseAccruedInterest · last filed 2022-11-14

Period end	Debt Instrument, Increase, Accrued Interest 9 month	Debt Instrument, Increase, Accrued Interest 12 month
2022-09-30	$7.36M 10-Q · filed 2022-11-14
2021-12-31		$11.96M 10-Q · filed 2022-11-14